ATE454887T1 - Therapeutisches system für die kontrollierte freisetzung von wirkstoffen - Google Patents

Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Info

Publication number
ATE454887T1
ATE454887T1 AT03732266T AT03732266T ATE454887T1 AT E454887 T1 ATE454887 T1 AT E454887T1 AT 03732266 T AT03732266 T AT 03732266T AT 03732266 T AT03732266 T AT 03732266T AT E454887 T1 ATE454887 T1 AT E454887T1
Authority
AT
Austria
Prior art keywords
release
tablet
constituted
active ingredient
active ingredients
Prior art date
Application number
AT03732266T
Other languages
English (en)
Inventor
Lauretta Maggi
Ubaldo Conte
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of ATE454887T1 publication Critical patent/ATE454887T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03732266T 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen ATE454887T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Publications (1)

Publication Number Publication Date
ATE454887T1 true ATE454887T1 (de) 2010-01-15

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03732266T ATE454887T1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Country Status (12)

Country Link
US (1) US20050095295A1 (de)
EP (1) EP1482915B1 (de)
JP (1) JP4664595B2 (de)
CN (1) CN100528146C (de)
AT (1) ATE454887T1 (de)
AU (1) AU2003239789A1 (de)
CA (1) CA2478406C (de)
DE (1) DE60330949D1 (de)
DK (1) DK1482915T3 (de)
ES (1) ES2339438T3 (de)
IT (1) ITMI20020514A1 (de)
WO (1) WO2003075897A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
EP2957281A1 (de) 2001-09-21 2015-12-23 Egalet Ltd. Polymer-freigabe-system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
EP2301526B1 (de) 2003-03-26 2016-03-23 Egalet Ltd. System zur kontrollierten Freisetzung von Morphin
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
PL1663175T3 (pl) * 2003-09-19 2012-09-28 Sun Pharma Advanced Res Co Ltd Doustny system podawania leku
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
WO2006122069A2 (en) * 2005-05-09 2006-11-16 Azur Pharma Formulations of mast cell stabilizing agents for delivery to the colon
NZ563846A (en) * 2005-06-03 2010-03-26 Egalet As A drug delivery system for delivering active substances dispersed in a dispersion medium
CN101351195A (zh) * 2005-11-18 2009-01-21 阿库布莱克科技公司 分段的药物剂量形式
EP2029116A4 (de) * 2006-06-19 2012-07-04 Accu Break Technologies Inc Segmentierte pharmazeutische dosierungsformen
WO2008148798A2 (en) * 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
JP2011512349A (ja) * 2008-02-15 2011-04-21 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 経口放出制御錠剤
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
EP2393487B1 (de) 2009-02-06 2016-11-02 Egalet Ltd. Gegen missbrauch resistente pharmazeutische zusammensetzungen
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
AU2012277375A1 (en) * 2011-06-29 2014-01-30 Sun Pharmaceutical Industries Limited Multilayered dosage form
US9549899B2 (en) 2012-07-06 2017-01-24 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
EP3592337B1 (de) 2017-03-08 2023-07-05 Cinrx Pharma, LLC Pharmazeutische formulierungen von phloroglucinol und trimethylphloroglucinol
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
WO2020006278A1 (en) * 2018-06-27 2020-01-02 Kashiv Biosciences, Llc Self-regulating osmotic gastroretentive drug delivery systems
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
AU7706598A (en) * 1997-05-30 1998-12-30 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
WO2001005430A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
EP1482915B1 (de) 2010-01-13
AU2003239789A1 (en) 2003-09-22
WO2003075897A1 (en) 2003-09-18
US20050095295A1 (en) 2005-05-05
EP1482915A1 (de) 2004-12-08
JP4664595B2 (ja) 2011-04-06
CA2478406A1 (en) 2003-09-18
JP2005526757A (ja) 2005-09-08
ITMI20020514A0 (it) 2002-03-12
CA2478406C (en) 2011-02-08
DK1482915T3 (da) 2010-04-19
ITMI20020514A1 (it) 2003-09-12
DE60330949D1 (de) 2010-03-04
CN1649571A (zh) 2005-08-03
ES2339438T3 (es) 2010-05-20
CN100528146C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
ATE454887T1 (de) Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
JP2005526757A5 (de)
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
BR0315023A (pt) Distribuidor de composição anti-séptica de pele e método de preparar um distribuidor de composição anti-séptica de pele para uso
EP0977614A1 (de) Vorrichtung zum behandeln von malignen, tumorösen gewebebereichen
ES2174073T3 (es) Forma farmaceutica solida para uso oral.
ATE446087T1 (de) Mikrokügelchen mit nanokapseln, die ein lipophiles arzneimittel enthalten
AR028849A1 (es) Articulo absorbente
ES2106818T3 (es) Composicion multicapa que contiene antagonistas de histamina o secotina.
Janczura et al. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
AR034517A1 (es) Formulacion farmaceutica
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
AR240381A1 (es) Composicones protectoras de las plantas basadas en emulsiones acuosas que contienen una o mas substancias activas, y procedimiento para su preparacion.
BRPI0315461B8 (pt) sistema terapêutico em forma de película
WO2003075894A8 (en) A system for the controlled release of active ingredients
PA8548301A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
JP2005526061A5 (de)
AR020205A1 (es) Formulacion efervescente esterilizante.
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
AR096223A1 (es) Pastilla de nicotina para administración oral
BR112021020951A2 (pt) Dispensação e retenção de agentes ativos dentro da pele
AR050627A1 (es) Composicion farmaceutica
AR024201A1 (es) Parche que contiene productos farmaceuticos, con tres capas funcionales

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties